Submitted on behalf of Stacey Tannenbaum:

Pharmacofriends and colleagues,

We are looking for a Director level Pharmacometrician for our team at Astellas. 
  Come work with me and an amazing group of scientists working on exciting drug 
development projects

We are open to remote work within the continental US.   Copy/paste this link 
into your browser (https://tinyurl.com/astellaspmx) and/or feel free to reach 
out to me directly at [email protected].  

Purpose & Scope
Provide scientific, technical, and strategic pharmacokinetic-pharmacodynamic 
modeling and simulation (M&S) support within and across therapeutic areas
Creation, review, and approval of scientific reports to document modeling 
activities and support registration
Writing of regulatory documents and interaction with regulatory agencies
May have mentoring/coaching or supervising responsibilities

Essential Job Responsibilities
Perform pharmacokinetic-pharmacodynamic modeling and simulation using a variety 
of software, which may include NONMEM, R, and SAS
Peer review of M&S reports and analyses
Make summaries and presentations of analyses to others
Manage and oversee outsourced projects
Contribute to the design, analysis, and reporting of clinical studies for a 
compound and provide M&S input to the clinical development strategy
Act as the M&S representative on Core Teams, Extended Teams, Early Modeling 
Teams, and Quantitative Quartet
Be actively involved in strategic modeling discussions with other 
pharmacometricians, and PBPK and QSP modelers
Represent M&S for in-house discovered or in-licensed compounds, which may 
include Due Diligence activities
Preparation of various sections of regulatory documents, such as IB, IND, and 
CTD, and interaction with regulatory agencies
May lead various working groups or initiatives to improve internal processes or 
best practices
Maintain knowledge of a particular disease area and M&S in general to ensure 
availability of state-of-the art knowledge and experience in pharmacometrics 
for practical application in clinical development
Mentoring of junior M&S scientists
May act as a Clinical Pharmacology core team member and leading Clinical 
Pharmacology Extended Teams
Contribute to the definition, implementation and maintenance of new 
multidisciplinary ways of working in order to improve the efficiency and 
effectiveness of the Pharmacometrics group and CPED
Display leadership attributes that lead to the improvement of Pharmacometrics 
and CPED processes and level of science
Contribution to and review of scientific, strategic, and technical documents 
produced by the Pharmacometrics Group

Quantitative Dimensions
Responsible for the design, analysis, and reporting of all M&S analyses 
associated with ~3 to 10 projects per year with ~1 to 4 projects at any given 
time
Responsible for management of timelines of M&S analyses related to particular 
studies
Responsible for management of costs and timelines of outsourced M&S analyses
May coach 1 to 2 new staff members on company and project team related 
procedures within Pharmacometrics and CPED
Responsibilities may directly impact on strategy and efficiency of clinical 
development of compounds.
May create and/or review 10 to 25 modeling reports per year for scientific and 
technical quality
The position has no direct budget responsibility

Organizational Context
This position reports to the Pharmacometrics US Group Lead
May have functional management of scientists
Direct interaction with the Quantitative Quartet (clinical, statistics, 
clinical pharmacology science), extended CPED team members, and core team 
partners

Required Qualifications:
Advanced degree MD/ PhD /PharmD/MS required
Requires at least 8 years post-graduate PhD/MD experience or 12 years post-MS 
in the pharmaceutical industry with a solid understanding of drug discovery and 
development
Can integrate knowledge across all CPED functions
Theoretical and working understanding of modeling and simulation of 
pharmacokinetic- pharmacodynamic data
Through understanding of pharmacokinetic-pharmacodynamic principles and how 
they are applied to clinical pharmacology
Basic understanding of disease biology and exposure-response M&S required to 
design early development strategies up to and including PoC
Expert working and theoretical knowledge of population 
pharmacokinetic-pharmacodynamic modeling methodologies and software
Working knowledge of Microsoft Office
Working knowledge with graphics software or tools
Expert working knowledge of a programming language such as SAS or R
Thorough understanding of regulatory strategies and guidelines
Experience in regulatory filings and interactions with regulatory authorities 
worldwide preferred
If this is a line management role, personnel management experienced highly 
desired
Demonstration of strategic thinking related to pharmacokinetic-pharmacodynamic 
exposure- response analyses and pooled analyses across a project
Good written and communication skills
Strong, critical analytical mind
Ability to operate with minimal supervision
Strong leadership skills


Stacey Tannenbaum, PhD, FISoP
Senior Director, Pharmacometrics US
Clinical Pharmacology and Exploratory Development
Astellas Pharma, Northbrook, IL 
Tel: 847-830-1598
<br /><br />
ICON plc made the following annotations.
------------------------------------------------------------------------------
This e-mail transmission may contain confidential or legally privileged 
information that is intended only for the individual or entity named in the 
e-mail address. If you
are not the intended recipient, you are hereby notified that any disclosure, 
copying, distribution, or reliance upon the contents of this e-mail is strictly 
prohibited. If
you have received this e-mail transmission in error, please reply to the 
sender, so that ICON plc can arrange for proper delivery, and then please 
delete the message.

Thank You,

ICON plc
South County Business Park
Leopardstown
Dublin 18
Ireland
Registered number: 145835

Reply via email to